Think of Lecanemab as Similar to Aducanumab for Alzheimer’s

April 2023

You’ll hear buzz about lecanemab (Leqembi), a new med for Alzheimer’s disease.

It joins aducanumab (Aduhelm) as the second IV monoclonal antibody to treat mild Alzheimer’s. Neither is for more severe disease.

Like aducanumab, lecanemab is touted to affect the underlying disease...by decreasing “amyloid plaque” in the brain.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Transitions of Care Reduce Med Errors at Care Transitions
Critical Care Ensure Safety With Vasopressors
Analgesics Avoid Errors With Local Anesthetics
Immunizations Know How the New Menveo Vaccine Stacks Up
Cardiology Help Keep Patients Taking Heart Rhythm Meds Safe
Alzheimer Disease Think of Lecanemab as Similar to Aducanumab for Alzheimer’s
COVID-19 Continue to Identify Patients Who May Need a Bivalent COVID-19 Booster
COVID-19 Help People Cope With Long COVID
Pain Management Be Familiar With Pain Treatment for Patients Taking Buprenorphine